Decision Diagnostics Current Valuation vs. Total Debt
| DECN Stock | USD 0.0001 0.00 0.00% |
For Decision Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Decision Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Decision Diagnostics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Decision Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Decision Diagnostics over time as well as its relative position and ranking within its peers.
Decision |
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Decision Diagnostics Total Debt vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Decision Diagnostics's current stock value. Our valuation model uses many indicators to compare Decision Diagnostics value to that of its competitors to determine the firm's financial worth. Decision Diagnostics is rated as one of the top companies in current valuation category among its peers. It is rated below average in total debt category among its peers making up about 0.95 of Total Debt per Current Valuation. The ratio of Current Valuation to Total Debt for Decision Diagnostics is roughly 1.05 . As of the 30th of November 2024, Total Debt To Capitalization is likely to drop to 0.94. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Decision Diagnostics' earnings, one of the primary drivers of an investment's value.Decision Current Valuation vs. Competition
Decision Diagnostics is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 36.27 Billion. Decision Diagnostics adds roughly 3.06 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Decision Total Debt vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Decision Diagnostics |
| = | 3.06 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Decision Diagnostics |
| = | 2.93 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Decision Total Debt vs Competition
Decision Diagnostics is rated below average in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 6.38 Billion. Decision Diagnostics adds roughly 2.93 Million in total debt claiming only tiny portion of equities under Health Care industry.
Decision Diagnostics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Decision Diagnostics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Decision Diagnostics will eventually generate negative long term returns. The profitability progress is the general direction of Decision Diagnostics' change in net profit over the period of time. It can combine multiple indicators of Decision Diagnostics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -1.9 M | -2 M | |
| Net Loss | -26.7 M | -25.4 M | |
| Income Before Tax | -26.7 M | -25.4 M | |
| Total Other Income Expense Net | -347.5 K | -364.9 K | |
| Net Loss | -26.7 M | -25.4 M | |
| Net Loss | -26.7 M | -25.4 M | |
| Income Tax Expense | 3.1 K | 3.3 K | |
| Net Interest Income | -24.5 M | -23.3 M | |
| Change To Netincome | 31.8 M | 33.4 M | |
| Net Loss | (0.10) | (0.11) | |
| Income Quality | 0.04 | 0.04 | |
| Net Income Per E B T | 1.15 | 0.81 |
Decision Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Decision Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Decision Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Decision Diagnostics' important profitability drivers and their relationship over time.
Use Decision Diagnostics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.Decision Diagnostics Pair Trading
Decision Diagnostics Pair Trading Analysis
The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Decision Diagnostics position
In addition to having Decision Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investing Thematic Idea Now
Investing
Companies involved in money management and investment banking services. The Investing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
To fully project Decision Diagnostics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Decision Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Decision Diagnostics' income statement, its balance sheet, and the statement of cash flows.